These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 16133732)
1. The natural course of non-classic Pompe's disease; a review of 225 published cases. Winkel LP; Hagemans ML; van Doorn PA; Loonen MC; Hop WJ; Reuser AJ; van der Ploeg AT J Neurol; 2005 Aug; 252(8):875-84. PubMed ID: 16133732 [TBL] [Abstract][Full Text] [Related]
2. [A retrospective study of six patients with late-onset Pompe disease]. Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925 [TBL] [Abstract][Full Text] [Related]
4. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987 [TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888 [TBL] [Abstract][Full Text] [Related]
6. [Pompe's disease. Part II. Treatment strategies and enzyme replacement]. Illés Z; Várdi Visy K Ideggyogy Sz; 2009 Sep; 62(9-10):299-307. PubMed ID: 19835271 [TBL] [Abstract][Full Text] [Related]
7. [Pompe's disease. Part I: pathogenesis and clinical features]. Illés Z; Trauninger A Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701 [TBL] [Abstract][Full Text] [Related]
8. Use of immobilized antibodies in investigating acid alpha-glucosidase in urine in relation to Pompe's disease. Schram AW; Brouwer-Kelder B; Donker-Koopman WE; Loonen C; Hamers MN; Tager JM Biochim Biophys Acta; 1979 Apr; 567(2):370-83. PubMed ID: 36157 [TBL] [Abstract][Full Text] [Related]
9. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. van den Hout HM; Hop W; van Diggelen OP; Smeitink JA; Smit GP; Poll-The BT; Bakker HD; Loonen MC; de Klerk JB; Reuser AJ; van der Ploeg AT Pediatrics; 2003 Aug; 112(2):332-40. PubMed ID: 12897283 [TBL] [Abstract][Full Text] [Related]
10. [Enzyme replacement therapy in Pompe's disease]. Merk T; Wibmer T; Schumann C; Krüger S Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875 [TBL] [Abstract][Full Text] [Related]
11. Adult glycogenosis type II (Pompe's disease): morphological abnormalities in muscle and skin biopsies compared with acid alpha-glucosidase activity. Wierzba-Bobrowicz T; Lewandowska E; Lugowska A; Rola R; Stepień T; Ryglewicz D; Pasennik E Folia Neuropathol; 2007; 45(4):179-86. PubMed ID: 18176891 [TBL] [Abstract][Full Text] [Related]
12. Pompe's disease. van der Ploeg AT; Reuser AJ Lancet; 2008 Oct; 372(9646):1342-53. PubMed ID: 18929906 [TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of acid alpha-glucosidase in late-onset forms of glycogenosis type II (Pompe's disease). Steckel F; Gieselmann V; Waheed A; Hasilik A; von Figura K; Oude Elferink R; Kalsbeek R; Tager JM FEBS Lett; 1982 Dec; 150(1):69-76. PubMed ID: 6761145 [TBL] [Abstract][Full Text] [Related]
18. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease]. Bereznai B; Trauninger A; György I; Szakszon K; Almássy Z; Pál E; Herczegfalvi A; Várdi Visy K; Illés Z; Molnár MJ Orv Hetil; 2011 Sep; 152(39):1569-75. PubMed ID: 21920843 [TBL] [Abstract][Full Text] [Related]
19. Glycogen storage disease type II (Pompe's disease): the first biochemical evidence in Thailand. Rangdaeng S; Scollard DM; Srichairatanakol S; Sutthachit M; Phornphutkul C J Med Assoc Thai; 1987 Sep; 70(9):536-42. PubMed ID: 2960768 [No Abstract] [Full Text] [Related]